Coronavirus Disease 2019 (COVID-19): A Perspective from China.
Zi Yue ZuMeng Di JiangPeng Peng XuWen ChenQian Qian NiGuang Ming LuLong Jiang ZhangPublished in: Radiology (2020)
In December 2019, an outbreak of severe acute respiratory syndrome coronavirus 2 infection occurred in Wuhan, Hubei Province, China, and spread across China and beyond. On February 12, 2020, the World Health Organization officially named the disease caused by the novel coronavirus as coronavirus disease 2019 (COVID-19). Because most patients infected with COVID-19 had pneumonia and characteristic CT imaging patterns, radiologic examinations have become vital in early diagnosis and the assessment of disease course. To date, CT findings have been recommended as major evidence for clinical diagnosis of COVID-19 in Hubei, China. This review focuses on the etiology, epidemiology, and clinical symptoms of COVID-19 while highlighting the role of chest CT in prevention and disease control.
Keyphrases
- coronavirus disease
- respiratory syndrome coronavirus
- sars cov
- computed tomography
- image quality
- contrast enhanced
- end stage renal disease
- newly diagnosed
- magnetic resonance imaging
- chronic kidney disease
- ejection fraction
- south africa
- physical activity
- intensive care unit
- patient reported outcomes
- extracorporeal membrane oxygenation
- clinical evaluation